Related Experiment Video
Updated: Aug 5, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Why "Treat First" Stalls: Knowledge, Scope, and System Determinants of Delayed Haemostatic Therapy in the Emergency
Emily Kraft1, Lindsay Cowley2, Vanessa Bourck3
1Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Background:
Persons with bleeding disorders (PwBD) frequently experience delays to haemostatic therapy in emergency departments (EDs). Identifying clinician knowledge gaps and workflow barriers is essential to accelerate time-to-treatment.
Objectives:
To define educational needs and system constraints shaping the evaluation and management of PwBD in Canadian EDs.
Methods:
We conducted an exploratory, sequential mixed-methods study. An online survey of ED nurses and physicians, distributed via national organizations, used four clinical vignettes to probe triage, diagnostic approach, initial management, and self-rated knowledge; quantitative data were summarized descriptively. Virtual focus groups then explored barriers and solutions and were analyzed using reflexive thematic analysis.
Results:
Three hundred ten clinicians completed the survey (250 nurses; 60 physicians). Most reported prior PwBD experience, but fewer had administered specialized haemostatic products. Across vignettes, respondents assigned high acuity and endorsed a ≤30-min treatment target, yet empiric "treat-first" therapy was inconsistently selected, particularly for non-specific presentations (severe headache, abdominal pain, early pregnancy bleeding). Reported gaps included use of haemostatic therapies; interpretation of coagulation assays; inhibitor management; and limited familiarity with treatment pathways. Barriers included absence of medical directives, treatment release processes, staffing and crowding pressures, and rural resource constraints. Six focus groups (nurses n = 10; physicians n = 4) explained these patterns, revealing a pathway from high perceived acuity to delayed treatment through intersecting knowledge, scope, and system factors, alongside strong preference for concise, point-of-care education, simulation, and web-based learning.
Conclusions:
Co-designed education, nurse-initiated directives, streamlined product release, and accessible point-of-care tools are complementary levers to compress triage-to-therapy intervals for PwBD.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis IV: Nursing Management
